Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer

PURPOSE: To report toxicity outcomes, prostate-specific antigen (PSA) relapse, and cumulative incidence posttreatment biopsy results among patients treated on a prospective dose escalation study using ultra-hypofractionated stereotactic body radiation therapy (SBRT) for patients with low- and interm...

Full description

Saved in:
Bibliographic Details
Published in:Int J Radiat Oncol Biol Phys
Main Authors: Zelefsky, Michael J., Kollmeier, Marisa, McBride, Sean, Varghese, Melissa, Mychalczak, Borys, Gewanter, Richard, Garg, Madhur K., Happersett, Laura, Goldman, Debra A., Pei, Isaac, Lin, Mary, Zhang, Zhigang, Cox, Brett W.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7525798/
https://ncbi.nlm.nih.gov/pubmed/30611838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2018.12.045
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items